Biomoda To Collaborate On Validation Study For Early Noninvasive Lung Cancer Diagnostic Testing

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Sept. 5, 2006--Mayo Clinic (Rochester, Minn.) and Biomoda Inc. (Albuquerque, N.M.) have agreed to jointly conduct a broad validation study of Biomoda's patented technology, a noninvasive cytology-based lung cancer diagnostic assay.

Back to news